How to Turn a Chicken Egg Into a Drug Factory

A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.

The New York Times
Inside The Turmoil at #RobertFKennedyJr #CDC 43 current and former C.D.C. employees on the changes they say are replacing #science with #ideology making Americans more vulnerable. NYT Gift Article "The civil servants who spoke to me worry that, instead, a century’s worth of expertise is being lost leaving Americans increasingly exposed to a wide range of #health threats." #publichealth #federalgovernment #vaccines #pandemic #drugs #pharmaceuticals #healthcare #government https://www.nytimes.com/interactive/2026/03/23/magazine/trump-rfk-jr-cdc-vaccines-maha.html?unlocked_article_code=1.WFA.iXoS.dxVXxyOb8wpb&smid=url-share
Inside the Turmoil at RFK Jr.’s CDC, as Told by Current and Former Employees

Forty-three current and former C.D.C. employees on the changes they say are replacing science with ideology — and making Americans more vulnerable.

The New York Times
Bain Capital-owned Tanabe Pharma is on the hunt for licensing deals abroad to bring medicines into Japan, betting that unmet patient demand and easing regulations will fuel growth. https://www.japantimes.co.jp/business/2026/03/26/companies/tanabe-pharma-licensing-deals-abroad/?utm_medium=Social&utm_source=mastodon #business #companies #tanabepharma #pharmaceuticals #medicine #bain
Bain-owned Tanabe Pharma targets global deals to fuel growth

A new team of around eight people in the U.S., in addition to an existing team in Japan, is sourcing therapies globally, particularly in rare diseases.

The Japan Times
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss

RE: https://mstdn.social/@TechCrunch/116205018327360404

A reliable technology for returning payloads to Earth from #space 🌌 is a necessity for several futuristic business models — testing new materials in orbit, manufacturing #pharmaceuticals 💊 or high-end #electronics in microgravity, or harvesting resources like metals from #asteroids.

Making satellites reusable ♻️ : "If you want to update a payload component every year, instead of having to build new #satellites 🛰️ and keep those old ones up in space, you can bring them down and go back"

Eli Lilly’s obesity drug retatrutide clears late-stage diabetes trial

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
#NewsBeep #News #Topstories #BiotechandPharmaceuticals #Biotechnology #BreakingNews:Business #Business #businessnews #EliLillyandCo #Headlines #Healthcareindustry #iSharesU.S.HealthcareETF #iSharesU.S.PharmaceuticalsETF #NovoNordiskA/S #Pharmaceuticals #TopStories
https://www.newsbeep.com/442200/

Africa: Pharma Pulls Back As Antimicrobial Resistance Threat Grows: [Independent (Kampala)] The rising threat of antimicrobial resistance (AMR) continues to expose deep structural weaknesses in global pharmaceutical markets, with drug-resistant infections projected to claim nearly two million lives annually by 2050 unless investment and policy responses accelerate, according to the 2026 AMR… http://newsfeed.facilit8.network/TRZg30 #AntimicrobialResistance #Pharmaceuticals #GlobalHealth #Healthcare #PublicHealth